These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15157997)

  • 41. Proton magnetic resonance spectroscopy study of dyskinesia patients.
    Kuznetsov Y; Khiat A; Blanchet PJ; Boulanger Y
    Mov Disord; 2007 May; 22(7):957-62. PubMed ID: 17377925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single voxel magnetic resonance spectroscopy at 3 Tesla in a memory disorders clinic: early right hippocampal NAA/Cr loss in mildly impaired subjects.
    Caserta MT; Ragin A; Hermida AP; Ahrens RJ; Wise L
    Psychiatry Res; 2008 Nov; 164(2):154-9. PubMed ID: 18930637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
    Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
    Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Alzheimer's disease and magnetic resonance spectroscopy of the hippocampus].
    Engelhardt E; Moreira DM; Laks J; Marinho VM; Rozenthal M; Oliveira AC
    Arq Neuropsiquiatr; 2001 Dec; 59(4):865-70. PubMed ID: 11733829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.
    Ciurleo R; Bonanno L; Di Lorenzo G; Bramanti P; Marino S
    Neurosci Lett; 2015 Jul; 599():55-60. PubMed ID: 26007705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
    Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
    Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Temporal pole proton preoperative magnetic resonance spectroscopy in patients undergoing surgery for mesial temporal sclerosis.
    Fountas KN; Tsougos I; Gotsis ED; Giannakodimos S; Smith JR; Kapsalaki EZ
    Neurosurg Focus; 2012 Mar; 32(3):E3. PubMed ID: 22380857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain metabolite changes in patients with type 2 diabetes and cerebral infarction using proton magnetic resonance spectroscopy.
    Zhang M; Sun X; Zhang Z; Meng Q; Wang Y; Chen J; Ma X; Geng H; Sun L
    Int J Neurosci; 2014 Jan; 124(1):37-41. PubMed ID: 23777574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proton MR spectroscopy: higher right anterior cingulate N-acetylaspartate/choline ratio in Asperger syndrome compared with healthy controls.
    Oner O; Devrimci-Ozguven H; Oktem F; Yagmurlu B; Baskak B; Munir KM
    AJNR Am J Neuroradiol; 2007 Sep; 28(8):1494-8. PubMed ID: 17846198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
    Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain MR spectroscopy in children with a history of rheumatic fever with a special emphasis on neuropsychiatric complications.
    Alkan A; Kutlu R; Kocak G; Sigirci A; Emul M; Dogan S; Aslan M; Sarac K; Yakinci C
    Eur J Radiol; 2004 Mar; 49(3):224-8. PubMed ID: 14962651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: a study using 3-Tesla proton magnetic resonance spectroscopy.
    Frye MA; Thomas MA; Yue K; Binesh N; Davanzo P; Ventura J; O'Neill J; Guze B; Curran JG; Mintz J
    Psychiatry Res; 2007 Apr; 154(3):259-65. PubMed ID: 17346949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton magnetic resonance spectroscopic imaging of cerebral gliomas: correlation of metabolite ratios with histopathologic grading.
    Hsu YY; Chang CN; Wie KJ; Lim KE; Hsu WC; Jung SM
    Chang Gung Med J; 2004 Jun; 27(6):399-407. PubMed ID: 15455540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proton MR spectroscopy in neuroborreliosis: a preliminary study.
    Ustymowicz A; Tarasów E; Zajkowska J; Walecki J; Hermanowska-Szpakowicz T
    Neuroradiology; 2004 Jan; 46(1):26-30. PubMed ID: 14663542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients.
    Olson BL; Holshouser BA; Britt W; Mueller C; Baqai W; Patra S; Petersen F; Kirsch WM
    Alzheimer Dis Assoc Disord; 2008; 22(3):269-77. PubMed ID: 18580584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolite alterations in autistic children: a 1H MR spectroscopy study.
    Kubas B; Kułak W; Sobaniec W; Tarasow E; Lebkowska U; Walecki J
    Adv Med Sci; 2012 Jun; 57(1):152-6. PubMed ID: 22472469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Proton magnetic resonance spectroscopy of prefrontal lobe and thalamus in schizophrenics: correlation with clinical characteristics].
    Gan JL; Duan HF; Yang JM; Shi ZJ; Zhang DW; Jiang ZK; Gao CY; Wang ZJ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(43):3034-9. PubMed ID: 22333054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).
    Tayoshi S; Sumitani S; Taniguchi K; Shibuya-Tayoshi S; Numata S; Iga J; Nakataki M; Ueno S; Harada M; Ohmori T
    Schizophr Res; 2009 Mar; 108(1-3):69-77. PubMed ID: 19097753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition.
    Byrnes V; Miller A; Lowry D; Hill E; Weinstein C; Alsop D; Lenkinski R; Afdhal NH
    J Hepatol; 2012 Mar; 56(3):549-56. PubMed ID: 22027578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.